Published in Vox Sang on January 01, 1999
Hepatitis B Awareness among Medical Students and Their Vaccination Status at Syrian Private University. Hepat Res Treat (2014) 0.90
Hepatitis B Virus Infection: Emerging Challenges for the Armed Forces. Med J Armed Forces India (2011) 0.78
World Hepatitis Day--new challenges. Indian J Med Res (2011) 0.76
A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol (2013) 3.19
Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management. Br J Surg (1998) 2.07
A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology (2007) 2.07
Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol (2007) 1.88
Endoscopic sclerotherapy using absolute alcohol. Gut (1985) 1.73
Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease. Am J Gastroenterol (1996) 1.70
Blood transfusion practices in India: results of a national survey. Indian J Gastroenterol (2000) 1.70
Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. Indian J Gastroenterol (2001) 1.67
P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India. Cancer (2000) 1.63
Coagulation profile and platelet function in patients with extrahepatic portal vein obstruction and non-cirrhotic portal fibrosis. J Gastroenterol Hepatol (2001) 1.52
Dietary and nutritional abnormalities in alcoholic liver disease: a comparison with chronic alcoholics without liver disease. Am J Gastroenterol (1997) 1.51
Portal biliopathy. J Gastroenterol Hepatol (2001) 1.51
The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients. Aliment Pharmacol Ther (2010) 1.50
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. J Viral Hepat (2013) 1.46
What is safe blood? J Assoc Physicians India (2000) 1.45
Increased frequency of gallstones in cirrhotic and non-cirrhotic portal hypertension. J Assoc Physicians India (2002) 1.42
Macrodystrophia lipomatosa: radiographic observations. Br J Radiol (1992) 1.41
Recombinant interferon therapy in Indian children with HBV related chronic liver disease. Indian Pediatr (2002) 1.39
High seroprevalence and clinical significance of hepatitis B and C infection in hospitalized patients with alcoholic cirrhosis. J Assoc Physicians India (2002) 1.39
Endoscopic biliary drainage by nasobiliary drain or by stent placement in patients with acute cholangitis. Endoscopy (2005) 1.39
Inferior vena caval obstruction due to amoebic liver abscess. J Assoc Physicians India (1982) 1.33
Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. J Hepatol (2000) 1.32
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis. J Viral Hepat (2012) 1.21
Role of HBV genotype in predicting response to lamivudine therapy in patients with chronic hepatitis B. Indian J Gastroenterol (2005) 1.20
Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther (2009) 1.19
Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. Gut (1986) 1.16
Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol (1997) 1.16
Comparative evaluation of plain films, ultrasound and CT in the diagnosis of intestinal obstruction. Acta Radiol (1999) 1.16
A case report of olanzapine-induced fecal incontinence. J Clin Psychiatry (2003) 1.10
Acute pancreatitis associated with viral hepatitis: a report of six cases with review of literature. Am J Gastroenterol (1999) 1.09
The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology (1995) 1.08
Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat (2013) 1.07
A case of hepatocellular carcinoma associated with troublesome hypoglycemia: management by cytoreduction using percutaneous ethanol injection. Am J Gastroenterol (1998) 1.07
Balloon tamponade in the management of bleeding oesophageal varices. Ann R Coll Surg Engl (1984) 1.06
Choledochal cysts--differences in children and adults. Br J Surg (1996) 1.06
Endoscopic management of liver abscesses and cysts that communicate with intrahepatic bile ducts. Endoscopy (2006) 1.05
Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol (2001) 1.04
Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status. Dig Dis Sci (2006) 1.04
Antibacterial efficacy of raw and processed honey. Biotechnol Res Int (2010) 1.04
Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients. J Viral Hepat (1999) 1.03
The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol (2003) 1.02
NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene (2009) 1.01
Pattern of alcohol-related liver disease in dependent alcoholics: the Indian dimension. Br J Addict (1988) 1.01
The outcome of research training during surgical residency. J Surg Res (2000) 1.01
Orbital mass lesions: US-guided fine-needle aspiration biopsy--experience in 37 patients. Radiology (1999) 1.00
Choledocholithiasis associated with portal biliopathy in patients with extrahepatic portal vein obstruction: management with endoscopic sphincterotomy. Gastrointest Endosc (1995) 0.99
Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter? J Assoc Physicians India (2002) 0.98
Repeated endoscopic sclerotherapy for active variceal bleeding. Ann Surg (1985) 0.98
Do umbilical vein catheterization and sepsis lead to portal vein thrombosis? A prospective, clinical, and sonographic evaluation. J Pediatr Gastroenterol Nutr (1993) 0.98
Corrosive oesophageal strictures following acid ingestion: clinical profile and results of endoscopic dilatation. J Gastroenterol Hepatol (1991) 0.98
Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM (2008) 0.96
Hepatic dysfunction in patients with extrahepatic portal venous obstruction. Liver Int (2003) 0.96
Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report. J Gastroenterol Hepatol (2001) 0.95
Follow-up of patients after variceal eradication. A comparison of patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction. Ann Surg (1986) 0.95
Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial. Gut (1987) 0.93
Tumoral calcinosis regression after subtotal parathyroidectomy: a case presentation and review of the literature. Surgery (1999) 0.93
A clinico-radiological reappraisal of intestinal tuberculosis--changing profile? Gastroenterol Jpn (1986) 0.93
The value of uterine artery Doppler in the prediction of uteroplacental complications in multiparous women. Ultrasound Obstet Gynecol (2004) 0.93
Hepatic manifestations in typhoid fever. Indian Pediatr (1994) 0.92
Endoscopic management of bile leaks after blunt abdominal trauma. J Gastroenterol Hepatol (2008) 0.92
Uterine choriocarcinoma in a postmenopausal woman. Med Oncol (2006) 0.92
Cholesterol and pigment gallstones in northern India. A prospective analysis. Dig Dis Sci (1986) 0.91
Transfusion associated hepatitis: the Indian scenario. Indian Pediatr (1997) 0.90
Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices. Aliment Pharmacol Ther (2009) 0.89
Hepatic visceral larva migrans: evolution of the lesion, diagnosis, and role of high-dose albendazole therapy. Am J Gastroenterol (1994) 0.89
Propofol sedation during endoscopy in patients with cirrhosis, and utility of psychometric tests and critical flicker frequency in assessment of recovery from sedation. Endoscopy (2011) 0.89
Absence of hemochromatosis associated Cys282Tyr HFE gene mutation and low frequency of hemochromatosis phenotype in nonalcoholic chronic liver disease patients in India. J Gastroenterol Hepatol (2004) 0.89
Autoimmune hepatitis in the Indian subcontinent: 7 years experience. J Gastroenterol Hepatol (2001) 0.88
Ulcerative colitis in a North Indian hospital: current trends. J R Coll Physicians Lond (1985) 0.88
Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach. Am J Gastroenterol (1989) 0.88
Image-guided fine-needle aspiration cytology of deep-seated enlarged lymph nodes. Acta Radiol (2002) 0.88
Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients. Hepatol Int (2010) 0.86
A novel second line chemotherapy treatment of recurrent thymoma. Med Oncol (1998) 0.86
Stress and uveitis. Ann Ophthalmol (1981) 0.86
Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci (1987) 0.86
Is cirrhosis of the liver reversible? Indian J Pediatr (2007) 0.86
Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors. Hum Gene Ther (2001) 0.85
Efficacy of low-dose alpha interferon therapy in HBV-related chronic liver disease in Asian Indians: a randomized controlled trial. J Hepatol (1996) 0.85
Subclinical encephalopathy after portosystemic shunts in patients with non-cirrhotic portal fibrosis. Liver (1985) 0.85
Histological subclassification of cirrhosis based on histological-haemodynamic correlation. Aliment Pharmacol Ther (2008) 0.85
The relationship between dose heterogeneity ("hot" spots) and complications following high-dose rate brachytherapy. Int J Radiat Oncol Biol Phys (1999) 0.84
Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. J Gastroenterol Hepatol (1999) 0.84
Identification of a novel surface mutant of hepatitis B virus in a seronegative chronic liver disease patient. Virus Res (1999) 0.84